From xhvby@ffrecoleta.com  Wed Apr 20 17:53:51 2005
Return-Path: <xhvby@ffrecoleta.com>
Received: from CPE000103696154-CM0012c91e02d6.cpe.net.cable.rogers.com (CPE000103696154-CM0012c91e02d6.cpe.net.cable.rogers.com [69.197.49.144])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3KMrfZG022428;
	Wed, 20 Apr 2005 17:53:46 -0500
Received: from dsebastian.com ([200.40.210.194])
          by citrus.cruz.as
          (InterMail vK.4.04.00.00 156-669-508 license 3cs477un9129o8au7a4lej1609a3kpp1)
          with ESMTP id <20036351444448.TRWK1218.chop@dsebastian.com>
          for <cypherpunks@al-qaeda.net>; Wed, 20 Apr 2005 18:51:35 -0500
Date: Wed, 20 Apr 2005 18:46:35 -0500
From: "Otis Hamm" <xhvby@ffrecoleta.com>
Subject: Stock insider reports penny pick secrets
X-Originating-IP: [193.71.199.94]
To: <cypherpunks@al-qaeda.net>
Message-ID: <003194852230.ZDO35553@benedikt.cruz.as>
MIME-version: 1.0
X-Mailer: Internet Mail Service (5.5.9916.21)
Content-type: text/plain
X-VirusChecked: Checked
X-Env-Sender: butterfield@dsebastian.com
X-StarScan-Version: 5.4.83; banners=S_FROM_DOMAIN,-,-
Original-recipient: rfc822;cypherpunks@al-qaeda.net
Status: O
Content-Length: 3442
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Total Shares Issued & Outstanding: 90,000,0O0 EST
Current Price: 0.06
20O4 Success |ead into an exciting 20O5.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutical drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9O01 industrial certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stab|e of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmastero|, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydrochlorrde, 1O-Deacetyl Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutica| and 
Neutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge gr0up of pheno|ic secondary 
metabo|ites of plants that include more than 2,O00 different known 
chemicals. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeability of the wal|s of the b|ood vesse|s inc|uding capi||aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 20O4-2O05 are more then  $1OO mi||iOn USD

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.

Penny stOcks are considered high|y speculative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  We were compensated 30O0 dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.

If you wish to stop future mailings, or if you feel you have been
wrongfu||y p|aced in our membership, please go here or send a blank
e mail with No Thanks in the subject to   st0ck1005  @yahoo.com      

